Drug recall · April 6, 2022
TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL recall
Why: Lack of sterility assurance.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TESTOSTERONE CYPIONATE/ ANASTROZOLE *GS* OIL (10ML) 200MG/0.5MG/ML; Packaged in a multi dose 10ML vial, as a) (CA) 4 ML Formula ID 136164; b) (RM) 10 ML Formula ID 115962; APS Phar
- Lots / codes
Lots: a)750851 BUD: 7/18/2022; b) 754549 BUD: 8/2/2022
- Quantity
- 73 vials
- Company
- Drug Depot, Inc., dba APS Pharmacy, Palm Harbor, FL
- Distribution
- Nationwide in the USA including Puerto Rico.
- Initiated
- March 23, 2022 · Voluntary: Firm initiated
- Classified
- March 29, 2022
- Reported
- April 6, 2022
- Ended
- October 5, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Testosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.